Analysis | Samples | Factors | Units |
---|---|---|---|
HILIC NEGATIVE ION MODE | 40 CAL120 GSK 1 uM | Sample source:CAL120 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 43 CAL120 GSK 1 uM | Sample source:CAL120 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 39 CAL120 DMM 5 mM | Sample source:CAL120 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 42 CAL120 DMM 5 mM | Sample source:CAL120 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 41 CAL120 Combination | Sample source:CAL120 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 44 CAL120 Combination | Sample source:CAL120 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 22 HCC1806 GSK 1 uM | Sample source:HCC1806 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 25 HCC1806 GSK 1 uM | Sample source:HCC1806 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 21 HCC1806 DMM 5 mM | Sample source:HCC1806 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 24 HCC1806 DMM 5 mM | Sample source:HCC1806 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 23 HCC1806 Combination | Sample source:HCC1806 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 26 HCC1806 Combination | Sample source:HCC1806 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 34 HS578T GSK 1 uM | Sample source:HS578T breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 37 HS578T GSK 1 uM | Sample source:HS578T breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 33 HS578T DMM 5 mM | Sample source:HS578T breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 36 HS578T DMM 5 mM | Sample source:HS578T breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 35 HS578T Combination | Sample source:HS578T breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 38 HS578T Combination | Sample source:HS578T breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 16 MCF7 GSK 1 uM | Sample source:MCF7 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 19 MCF7 GSK 1 uM | Sample source:MCF7 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 15 MCF7 DMM 5 mM | Sample source:MCF7 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 18 MCF7 DMM 5 mM | Sample source:MCF7 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 17 MCF7 Combination | Sample source:MCF7 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 20 MCF7 Combination | Sample source:MCF7 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 28 MDA-MB-231 GSK 1 uM | Sample source:MDA-MB-231 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 31 MDA-MB-231 GSK 1 uM | Sample source:MDA-MB-231 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 27 MDA-MB-231 DMM 5 mM | Sample source:MDA-MB-231 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 30 MDA-MB-231 DMM 5 mM | Sample source:MDA-MB-231 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 29 MDA-MB-231 Combination | Sample source:MDA-MB-231 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 32 MDA-MB-231 Combination | Sample source:MDA-MB-231 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 04 MDA-MB-468 GSK 1 uM | Sample source:MDA-MB-468 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 07 MDA-MB-468 GSK 1 uM | Sample source:MDA-MB-468 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 03 MDA-MB-468 DMM 5 mM | Sample source:MDA-MB-468 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 06 MDA-MB-468 DMM 5 mM | Sample source:MDA-MB-468 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 05 MDA-MB-468 Combination | Sample source:MDA-MB-468 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 08 MDA-MB-468 Combination | Sample source:MDA-MB-468 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 01 Blank | Sample source:NA | Sample Type:Blank | Drug Treatment:NA | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 46 Blank | Sample source:NA | Sample Type:Blank | Drug Treatment:NA | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 02 DMEM/F12 no adds | Sample source:NA | Sample Type:QC | Drug Treatment:NA | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 45 DMEM/F12 no adds | Sample source:NA | Sample Type:QC | Drug Treatment:NA | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 10 SUM159PT GSK 1 uM | Sample source:SUM159PT breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 13 SUM159PT GSK 1 uM | Sample source:SUM159PT breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 09 SUM159PT DMM 5 mM | Sample source:SUM159PT breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 12 SUM159PT DMM 5 mM | Sample source:SUM159PT breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 11 SUM159PT Combination | Sample source:SUM159PT breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC NEGATIVE ION MODE | 14 SUM159PT Combination | Sample source:SUM159PT breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 40 CAL120 GSK 1 uM | Sample source:CAL120 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 43 CAL120 GSK 1 uM | Sample source:CAL120 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 39 CAL120 DMM 5 mM | Sample source:CAL120 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC POSITIVE ION MODE | 42 CAL120 DMM 5 mM | Sample source:CAL120 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC POSITIVE ION MODE | 41 CAL120 Combination | Sample source:CAL120 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 44 CAL120 Combination | Sample source:CAL120 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 22 HCC1806 GSK 1 uM | Sample source:HCC1806 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 25 HCC1806 GSK 1 uM | Sample source:HCC1806 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 21 HCC1806 DMM 5 mM | Sample source:HCC1806 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC POSITIVE ION MODE | 24 HCC1806 DMM 5 mM | Sample source:HCC1806 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC POSITIVE ION MODE | 23 HCC1806 Combination | Sample source:HCC1806 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 26 HCC1806 Combination | Sample source:HCC1806 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 34 HS578T GSK 1 uM | Sample source:HS578T breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 37 HS578T GSK 1 uM | Sample source:HS578T breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 33 HS578T DMM 5 mM | Sample source:HS578T breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC POSITIVE ION MODE | 36 HS578T DMM 5 mM | Sample source:HS578T breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC POSITIVE ION MODE | 35 HS578T Combination | Sample source:HS578T breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 38 HS578T Combination | Sample source:HS578T breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 16 MCF7 GSK 1 uM | Sample source:MCF7 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 19 MCF7 GSK 1 uM | Sample source:MCF7 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 15 MCF7 DMM 5 mM | Sample source:MCF7 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC POSITIVE ION MODE | 18 MCF7 DMM 5 mM | Sample source:MCF7 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC POSITIVE ION MODE | 17 MCF7 Combination | Sample source:MCF7 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 20 MCF7 Combination | Sample source:MCF7 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 28 MDA-MB-231 GSK 1 uM | Sample source:MDA-MB-231 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 31 MDA-MB-231 GSK 1 uM | Sample source:MDA-MB-231 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 27 MDA-MB-231 DMM 5 mM | Sample source:MDA-MB-231 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC POSITIVE ION MODE | 30 MDA-MB-231 DMM 5 mM | Sample source:MDA-MB-231 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC POSITIVE ION MODE | 29 MDA-MB-231 Combination | Sample source:MDA-MB-231 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 32 MDA-MB-231 Combination | Sample source:MDA-MB-231 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 04 MDA-MB-468 GSK 1 uM | Sample source:MDA-MB-468 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 07 MDA-MB-468 GSK 1 uM | Sample source:MDA-MB-468 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 03 MDA-MB-468 DMM 5 mM | Sample source:MDA-MB-468 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC POSITIVE ION MODE | 06 MDA-MB-468 DMM 5 mM | Sample source:MDA-MB-468 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC POSITIVE ION MODE | 05 MDA-MB-468 Combination | Sample source:MDA-MB-468 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 08 MDA-MB-468 Combination | Sample source:MDA-MB-468 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 01 Blank | Sample source:NA | Sample Type:Blank | Drug Treatment:NA | Counts per second (cps) |
HILIC POSITIVE ION MODE | 46 Blank | Sample source:NA | Sample Type:Blank | Drug Treatment:NA | Counts per second (cps) |
HILIC POSITIVE ION MODE | 02 DMEM/F12 no adds | Sample source:NA | Sample Type:QC | Drug Treatment:NA | Counts per second (cps) |
HILIC POSITIVE ION MODE | 45 DMEM/F12 no adds | Sample source:NA | Sample Type:QC | Drug Treatment:NA | Counts per second (cps) |
HILIC POSITIVE ION MODE | 10 SUM159PT GSK 1 uM | Sample source:SUM159PT breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 13 SUM159PT GSK 1 uM | Sample source:SUM159PT breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 09 SUM159PT DMM 5 mM | Sample source:SUM159PT breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC POSITIVE ION MODE | 12 SUM159PT DMM 5 mM | Sample source:SUM159PT breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate | Counts per second (cps) |
HILIC POSITIVE ION MODE | 11 SUM159PT Combination | Sample source:SUM159PT breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |
HILIC POSITIVE ION MODE | 14 SUM159PT Combination | Sample source:SUM159PT breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069 | Counts per second (cps) |